To investigate whether adjudin-pretreated NSCs in the acute phase of cerebral ischemia had a better effect on immunomodulatory influence, we first examined IL-6, IL-1β, and TNF-α mRNA expression in both the cortex and the striatum. This evidence concerns the gene IL1B and brain ischemia.